PL1938832T3 - Peptydy jako czynniki hamujące enzym przekształcający angiotensynę - Google Patents

Peptydy jako czynniki hamujące enzym przekształcający angiotensynę

Info

Publication number
PL1938832T3
PL1938832T3 PL08153738T PL08153738T PL1938832T3 PL 1938832 T3 PL1938832 T3 PL 1938832T3 PL 08153738 T PL08153738 T PL 08153738T PL 08153738 T PL08153738 T PL 08153738T PL 1938832 T3 PL1938832 T3 PL 1938832T3
Authority
PL
Poland
Prior art keywords
angiotensin
converting enzyme
enzyme inhibitory
inhibitory peptides
peptides
Prior art date
Application number
PL08153738T
Other languages
English (en)
Inventor
Kyoichi Ogura
Taeko Iino
Sumio Asami
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of PL1938832T3 publication Critical patent/PL1938832T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL08153738T 2003-03-18 2004-03-17 Peptydy jako czynniki hamujące enzym przekształcający angiotensynę PL1938832T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003074488 2003-03-18
EP04721339A EP1605969B1 (en) 2003-03-18 2004-03-17 Angiotensin-converting enzyme inhibitory peptides
EP08153738A EP1938832B1 (en) 2003-03-18 2004-03-17 Angiotensin-converting enzyme inhibitory peptides

Publications (1)

Publication Number Publication Date
PL1938832T3 true PL1938832T3 (pl) 2013-06-28

Family

ID=33027809

Family Applications (3)

Application Number Title Priority Date Filing Date
PL04721339T PL1605969T3 (pl) 2003-03-18 2004-03-17 Peptydy jako czynniki hamujące enzym przekształcający angiotensynę
PL08153738T PL1938832T3 (pl) 2003-03-18 2004-03-17 Peptydy jako czynniki hamujące enzym przekształcający angiotensynę
PL09172830T PL2145630T3 (pl) 2003-03-18 2004-03-17 Peptydy jako czynniki hamujące enzym, przekształcający angiotensynę

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04721339T PL1605969T3 (pl) 2003-03-18 2004-03-17 Peptydy jako czynniki hamujące enzym przekształcający angiotensynę

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL09172830T PL2145630T3 (pl) 2003-03-18 2004-03-17 Peptydy jako czynniki hamujące enzym, przekształcający angiotensynę

Country Status (15)

Country Link
US (2) US7833985B2 (pl)
EP (3) EP1605969B1 (pl)
JP (3) JP4283848B2 (pl)
KR (3) KR101119449B1 (pl)
CN (1) CN100402089C (pl)
AU (3) AU2004222435B2 (pl)
CA (3) CA2526891C (pl)
CY (1) CY1114072T1 (pl)
DK (1) DK1605969T3 (pl)
ES (3) ES2400561T3 (pl)
HK (1) HK1084604A1 (pl)
PL (3) PL1605969T3 (pl)
PT (1) PT1605969E (pl)
TW (3) TWI328457B (pl)
WO (1) WO2004082709A1 (pl)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4046708B2 (ja) * 2004-06-04 2008-02-13 明治製菓株式会社 ３−アルケニルセフェム化合物の製造方法
JP2006219420A (ja) * 2005-02-10 2006-08-24 Nagase Chemtex Corp 抗高血圧剤
AU2006239562B2 (en) * 2005-04-28 2010-12-23 Unilever Plc Compositions comprising tripeptides inhibiting ace
AU2006239560B2 (en) * 2005-04-28 2010-03-25 Unilever Plc Peptides having an ace inhibiting effect
WO2006114194A1 (en) * 2005-04-28 2006-11-02 Unilever N.V. Peptides having a health benefit and compositions comprising them
US20090304869A1 (en) * 2005-04-28 2009-12-10 Christianus Jacobus Van Platerink Peptides Having an Ace Inhibiting Effect
ATE453399T1 (de) * 2005-05-24 2010-01-15 Chr Hansen As Isolierte dipeptide mit ace-inhibitionseffekt
JP4994093B2 (ja) * 2006-04-13 2012-08-08 ロート製薬株式会社 育毛剤
CN100456948C (zh) * 2006-06-30 2009-02-04 北京三友汇智生物技术有限公司 一种燕麦肽及其提取方法
KR100787949B1 (ko) * 2007-08-29 2007-12-24 한양대학교 산학협력단 대두 발효 조성물의 제조방법 및 이 조성물로부터 유래된펩타이드
JP2009073765A (ja) * 2007-09-20 2009-04-09 Nitsukoku Seifun Kk アンジオテンシン変換酵素（ａｃｅ）阻害剤組成物及びその製造方法
JP2010163400A (ja) * 2009-01-19 2010-07-29 Kikkoman Corp 新規アンジオテンシン変換酵素阻害ペプチド
CN101618207B (zh) * 2009-06-17 2011-08-03 中国科学院大连化学物理研究所 多肽在制备ace抑制剂及降血压药物中的应用
US20120157395A1 (en) * 2009-07-13 2012-06-21 Masahisa Ibuki Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application
CN101696233B (zh) * 2009-10-29 2012-02-01 吉林大学 蛋清蛋白血管紧张素转化酶抑制肽及其制备
JP5654290B2 (ja) * 2010-08-27 2015-01-14 ユニチカ株式会社 アンジオテンシン変換酵素阻害ペプチド及びその製造方法。
CN102399261B (zh) * 2010-09-07 2014-06-25 任发政 具有血管紧张素转化酶c-端选择性抑制活性的三肽及其应用和组合物
CN102475884B (zh) * 2010-11-29 2013-08-14 中国科学院大连化学物理研究所 四个多肽在制备ace抑制剂及降血压药物中的应用
CN102276690B (zh) * 2011-08-05 2013-03-20 成都中医药大学 降血压功能性多肽及其用途
JP6296722B2 (ja) * 2012-07-31 2018-03-20 サンスター株式会社 米糠酵素処理組成物
KR101481416B1 (ko) * 2012-10-17 2015-01-13 건국대학교 산학협력단 안지오텐신 전환 효소 저해 활성을 갖는 펩타이드
JP2014141462A (ja) * 2012-12-27 2014-08-07 Raffinee International Co Ltd ペプチド、並びに、アンジオテンシン変換酵素阻害剤、抗高血圧剤、及び飲食品
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CA2901469A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc. Rice protein supplements
CN103172698B (zh) * 2013-04-10 2015-02-18 华东理工大学 降血压多肽
CN103242430B (zh) * 2013-05-31 2014-10-08 南京中医药大学 血管紧张素转化酶抑制肽及其制备方法和应用
CN103290086B (zh) * 2013-06-25 2015-01-14 广州合诚实业有限公司 具有ace抑制活性的绿豆蛋白肽及其制备方法与应用
CN104558110B (zh) * 2013-10-21 2018-06-08 中国科学院大连化学物理研究所 具有ace抑制活性的多肽及其在降血压药物中的应用
CN104558109B (zh) * 2013-10-21 2018-06-08 中国科学院大连化学物理研究所 源于油菜花粉的具有ace抑制活性的多肽化合物及应用
CN107417768B (zh) * 2014-11-25 2021-01-29 烟台市华昕生物医药科技有限公司 一种从荠莱中分离获得的降血压多肽
JP6987757B2 (ja) * 2016-06-16 2022-01-05 サンスター株式会社 新規トリペプチド
CN106188227B (zh) * 2016-07-07 2019-09-24 华东理工大学 降血压肽和降血压蛋白质及其应用
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION
WO2019006951A1 (zh) * 2017-07-07 2019-01-10 广州世优生物科技有限公司 非极性二肽在制备降血压药物或保健品中的应用
CN110498833B (zh) * 2019-08-30 2021-01-15 华南理工大学 一种具有ace抑制作用的三肽及其应用
JP7391738B2 (ja) 2020-03-19 2023-12-05 Ｋｉｓｃｏ株式会社 ペプチド、及び苦味付与剤
CN111548387B (zh) * 2020-03-31 2020-12-18 华南农业大学 一种具有降血压功效的寡肽及其制备方法与应用
CN111471086B (zh) * 2020-04-16 2023-01-24 河南省农业科学院 芝麻多肽及其制备方法和应用
CN111825754B (zh) * 2020-07-16 2022-02-11 河南省农业科学院 一种从芝麻蛋白中获得的具有降血压与降血糖活性的多肽
WO2022168413A1 (ja) * 2021-02-04 2022-08-11 ユーハ味覚糖株式会社 デプレスタチン含有組成物の製造方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52148631A (en) 1976-06-01 1977-12-10 Kitazato Daigaku Yakurigakubu Enzym obstruction agent
DE3112394A1 (de) * 1980-07-22 1982-07-08 Eltreva AG, 4147 Aesch "einrichtung zur luftregulierung einer energiefassade"
JPS6023085B2 (ja) 1981-12-23 1985-06-05 工業技術院長 アンジオテンシン転換酵素阻害剤
US5156840A (en) * 1982-03-09 1992-10-20 Cytogen Corporation Amine-containing porphyrin derivatives
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
JPS6023086B2 (ja) 1982-09-04 1985-06-05 工業技術院長 アンジオテンシン転換酵素阻害剤
JPS6023087A (ja) 1983-07-20 1985-02-05 Canon Inc リボンカセツト
JPS6023086A (ja) 1983-07-20 1985-02-05 Canon Inc リボンカセツト
MX7527E (es) * 1983-08-16 1989-07-25 Univ Georgia Res Found Procedimiento para la sintesis de un aminoacido de ciclopropilo
JPS6136226A (ja) 1984-07-28 1986-02-20 Agency Of Ind Science & Technol アンジオテンシン転換酵素阻害剤
JPS6136227A (ja) 1984-07-28 1986-02-20 Agency Of Ind Science & Technol アンジオテンシン転換酵素阻害剤
JPS6286741A (ja) 1985-10-11 1987-04-21 Mitsubishi Electric Corp パタ−ンの位置合わせずれ量評価方法
JP2805032B2 (ja) 1988-07-27 1998-09-30 工業技術院長 アンジオテンシン変換酵素阻害剤
JP2873318B2 (ja) 1989-03-14 1999-03-24 工業技術院長 血圧降下剤
JPH0311097A (ja) 1989-06-07 1991-01-18 Senmi Ekisu Kk 新規ペプチド
JPH0623086B2 (ja) 1989-07-19 1994-03-30 花王株式会社 洗浄剤組成物
DE69124274T2 (de) 1990-02-27 1997-08-14 Agency Ind Science Techn Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
JP3103363B2 (ja) * 1990-03-30 2000-10-30 昭和産業株式会社 新規トリペプチド及び血圧降下剤
JP3073762B2 (ja) 1990-10-03 2000-08-07 日本合成化学工業株式会社 アンギオテンシン変換酵素阻害剤含有組成物の製造方法
JPH06136227A (ja) 1992-10-22 1994-05-17 Nippon Steel Chem Co Ltd 熱可塑性樹脂組成物
JP3357097B2 (ja) 1992-10-27 2002-12-16 株式会社クラレ 耐衝撃性メタクリル樹脂組成物
JP2820868B2 (ja) 1993-08-27 1998-11-05 日清食品株式会社 アンジオテンシン変換酵素阻害蛋白分解物
WO1995009868A1 (fr) * 1993-10-04 1995-04-13 Institut Pasteur Composes modifiant la transmission serotoninergique; applications diagnostiques et therapeutiques
US5558993A (en) * 1994-06-17 1996-09-24 The Regents Of The University Of California Cloned Borrelia burgdorferi virulence protein
JP3135812B2 (ja) 1995-03-01 2001-02-19 日清食品株式会社 アンジオテンシン変換酵素阻害ペプチドおよびその製造方法
JP3567012B2 (ja) 1995-03-28 2004-09-15 雪印乳業株式会社 新規ペプチド及びその利用
JP3028411B2 (ja) * 1997-09-26 2000-04-04 カルピス株式会社 トリペプチド高生産性ラクトバチルス・ヘルベチカス乳酸菌
JP4727770B2 (ja) * 1997-09-26 2011-07-20 カルピス株式会社 尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
PL354122A1 (pl) * 1999-08-09 2003-12-29 Tripep Abtripep Ab Inhibitory polimeryzacji białek i sposoby ich zastInhibitory polimeryzacji białek i sposoby ich zastosowaniaosowania
JP3592593B2 (ja) * 1999-10-15 2004-11-24 日本合成化学工業株式会社 アンギオテンシン変換酵素阻害剤
FI113741B (fi) * 1999-11-01 2004-06-15 Valio Oy Menetelmä verenpainetta alentavia peptidejä sisältävän tuotteen valmistamiseksi
WO2001068115A1 (en) * 2000-03-13 2001-09-20 Monsanto Technology Llc Process for producing peptide sequences possessing anti-hypertension activity
WO2001081368A2 (en) * 2000-04-21 2001-11-01 Monsanto Technology Llc Blood-pressure reducing polypeptides containing vpp derived from microorganisms
CN1491278A (zh) * 2001-02-07 2004-04-21 ŵά�Ź�˾ 脂酶变体
JP4144696B2 (ja) 2002-11-07 2008-09-03 タイヨーエレック株式会社 遊技機

Also Published As

Publication number Publication date
ES2400308T3 (es) 2013-04-09
PL2145630T3 (pl) 2013-04-30
AU2004222435B2 (en) 2009-12-17
CA2743313C (en) 2013-08-13
AU2009236033B2 (en) 2012-04-26
CA2743313A1 (en) 2004-09-30
CA2743539C (en) 2013-08-13
EP2145630A2 (en) 2010-01-20
JP4283848B2 (ja) 2009-06-24
KR20050111778A (ko) 2005-11-28
EP1605969A1 (en) 2005-12-21
ES2400561T3 (es) 2013-04-10
PL1605969T3 (pl) 2013-06-28
CN100402089C (zh) 2008-07-16
KR20110015675A (ko) 2011-02-16
TWI411441B (zh) 2013-10-11
AU2009236033A1 (en) 2009-12-03
CY1114072T1 (el) 2016-07-27
KR101077801B1 (ko) 2011-10-28
US20090318368A1 (en) 2009-12-24
TWI344371B (en) 2011-07-01
DK1605969T3 (da) 2013-04-29
EP2145630A3 (en) 2010-02-17
EP1938832B1 (en) 2013-02-13
JP4369985B2 (ja) 2009-11-25
JP2006520809A (ja) 2006-09-14
TW201125574A (en) 2011-08-01
JP4369986B2 (ja) 2009-11-25
JP2009084295A (ja) 2009-04-23
HK1084604A1 (en) 2006-08-04
US7943578B2 (en) 2011-05-17
CA2526891A1 (en) 2004-09-30
TW200507871A (en) 2005-03-01
US20060276627A1 (en) 2006-12-07
EP1605969B1 (en) 2013-02-13
TW200902053A (en) 2009-01-16
KR101119449B1 (ko) 2012-03-16
EP2145630B1 (en) 2013-01-09
KR101078628B1 (ko) 2011-11-01
EP1938832A1 (en) 2008-07-02
ES2398788T3 (es) 2013-03-21
CA2743539A1 (en) 2004-09-30
KR20110015674A (ko) 2011-02-16
PT1605969E (pt) 2013-03-27
US7833985B2 (en) 2010-11-16
WO2004082709A1 (en) 2004-09-30
CN1780639A (zh) 2006-05-31
CA2526891C (en) 2013-08-13
AU2009236034B2 (en) 2012-04-26
JP2009084294A (ja) 2009-04-23
AU2009236034A1 (en) 2009-12-03
TWI328457B (en) 2010-08-11
AU2004222435A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
HK1084604A1 (en) Angiotensin-converting enzyme inhibitory peptides
HK1209652A1 (en) Uses of aromatic-cationic peptide
AU2003238930A8 (en) Enzymes
SI1794180T1 (sl) Peptidna ciklizacija
AU2003290563A8 (en) Leptin-related peptides
GB0324265D0 (en) Peptide
EP1534308A4 (en) PEPTIDES WITH INHIBITORY ACTION OF GROWTH
EP1486507A4 (en) PEPTIDE INHIBITOR OF TRANSMEMBRANE NFAT
AU2003295462A1 (en) Lipid-associated proteins
AU2003205623A8 (en) Prion protein carrier-conjugates
AU2003245747A8 (en) Enzymes
AU2003216376A8 (en) Enzymes
GB0213745D0 (en) Enzyme
AU2003225282A8 (en) Enzymes
AU2003220607A8 (en) Enzymes
GB0202275D0 (en) Peptide
GB2413329B (en) Novel Enzymes
AU2003294219A8 (en) Enzymes
GB0210746D0 (en) Peptide
GB0310457D0 (en) Enzyme
GB0219980D0 (en) Peptides
GB0319579D0 (en) Enzyme
GB0204684D0 (en) Enzyme
GB0205112D0 (en) Enzyme
GB0219931D0 (en) Enzyme